The S&P 500 rebounded in May, but some stocks crashed on company-specific concerns. While one healthcare giant withdrew its ...

A nonprofit backed by the DNA-testing firm's former CEO, Anne Wojcicki, bid $305 million to take control of the company.

Also this week, more than two dozen states sued 23andMe to challenge the sale of its customers’ private data. The states argue the company must obtain explicit consent from its ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

Several states have joined a lawsuit against 23andme. They say bankruptcy shouldn't allow the genetic testing company to sell ...

Welcome to the future, folks—where AI is regulated, genetic testing companies have more plot twists than a soap opera, and ...